TRAVERE THERAPEUTICS, INC. (TVTX)
Clinical trial NCT06431893 updates: 1. completion date: 2027-01-01 → 2030-08-01 2. primary completion date: 2027-01-01 → 2030-08-01 3. enrollment: not set → 100 participants
Clinical trial NCT06431893 updates: 1. completion date: 2027-01-01 → 2030-08-01 2. primary completion date: 2027-01-01 → 2030-08-01 3. enrollment: not set → 100 participants
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical